Niet invasieve inschatting van cardiovasculair risico en het risico op diabetes

Klinisch gevalideerd en eenvoudig in gebruik

View our products

Advanced Glycation Endproducts

Cardiovasculair risk

Vraag informatie aan
Informatie aanvraag

Wil je meer weten over onze producten? Vraag dan nu informatie aan.

The AGE Reader App!
Age Reader APP
The new AGE Reader App allows you to generate a comprehensive Cardiovascular Risk Report based on the AGE Reader measurement. For each patient all visits can be documented and consulted in the easy to use App.

Read more »

The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or Diagnoptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.

Over het bedrijf

Informatie over Diagnoptics

Informatie voor pati├źnten

Informatie over Diagnoptics producten en Advanced Glycation Endproducts (versuikerde eiwitten)

Informatie voor professionals

Informatie over Advanced Glycation Endproducts, de AGE meting en de klinische validatie.